{"SPADE_UN_14454": {"basic": {"SPADE ID": "SPADE_UN_14454", "Peptide Name": "LP-51", "Sequence": "LEANIEELLKKAEEQQKKNEEELKKLEX", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial", "Antiviral"], "Target Organism": "[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=21±10 pM);HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=6±1 pM);HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=27±5 pM);T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50<0.01 nM);T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.02-12.07 nM);HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=0.09-0.84 nM);SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.03-0.06 nM).", "Linear/Cyclic": "Linear", "Sequence Length": 28}, "extended_data_url": "SPADE_UN_14454_extended.json"}}